2202 North West Shore Boulevard
Suite 200
Tampa, FL 33607
United States
888 664 2983
https://www.hcyte.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 8
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Michael W. Yurkowsky | CEO & Director | 180k | N/A | 1972 |
Mr. Jeremy D. Daniel | Chief Financial Officer | 200k | N/A | 1976 |
Dr. Tanya Rhodes Ph.D. | Chief Scientific Officer | 252k | N/A | 1961 |
Mr. Jeffery Wright CPA, CPA | Controller & Principal Accounting Officer | N/A | N/A | 1983 |
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
H-CYTE, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.